1. Home
  2. ALOT vs ABOS Comparison

ALOT vs ABOS Comparison

Compare ALOT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • ABOS
  • Stock Information
  • Founded
  • ALOT 1969
  • ABOS 1996
  • Country
  • ALOT United States
  • ABOS United States
  • Employees
  • ALOT N/A
  • ABOS N/A
  • Industry
  • ALOT Computer peripheral equipment
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALOT Technology
  • ABOS Health Care
  • Exchange
  • ALOT Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • ALOT 66.7M
  • ABOS 66.6M
  • IPO Year
  • ALOT N/A
  • ABOS 2021
  • Fundamental
  • Price
  • ALOT $8.98
  • ABOS $0.98
  • Analyst Decision
  • ALOT
  • ABOS Strong Buy
  • Analyst Count
  • ALOT 0
  • ABOS 3
  • Target Price
  • ALOT N/A
  • ABOS $7.33
  • AVG Volume (30 Days)
  • ALOT 14.8K
  • ABOS 211.3K
  • Earning Date
  • ALOT 06-05-2025
  • ABOS 05-13-2025
  • Dividend Yield
  • ALOT N/A
  • ABOS N/A
  • EPS Growth
  • ALOT N/A
  • ABOS N/A
  • EPS
  • ALOT N/A
  • ABOS N/A
  • Revenue
  • ALOT $151,283,000.00
  • ABOS N/A
  • Revenue This Year
  • ALOT N/A
  • ABOS N/A
  • Revenue Next Year
  • ALOT N/A
  • ABOS N/A
  • P/E Ratio
  • ALOT N/A
  • ABOS N/A
  • Revenue Growth
  • ALOT 2.16
  • ABOS N/A
  • 52 Week Low
  • ALOT $7.53
  • ABOS $0.86
  • 52 Week High
  • ALOT $18.25
  • ABOS $3.92
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 54.06
  • ABOS 42.74
  • Support Level
  • ALOT $8.00
  • ABOS $0.96
  • Resistance Level
  • ALOT $9.40
  • ABOS $1.13
  • Average True Range (ATR)
  • ALOT 0.33
  • ABOS 0.09
  • MACD
  • ALOT 0.18
  • ABOS 0.00
  • Stochastic Oscillator
  • ALOT 74.09
  • ABOS 14.26

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: